Long-term vagus nerve stimulation in children with focal epilepsy

Acta Neurol Scand. 2013 May;127(5):316-22. doi: 10.1111/ane.12009. Epub 2012 Sep 20.

Abstract

Objectives: The aim of the study was to evaluate the long-term efficacy and hospitalization rates in children with refractory focal epilepsy treated by vagus nerve stimulation.

Materials and methods: We retrospectively analyzed 15 children with intractable focal epilepsy treated by vagus nerve stimulation (mean age of 14.6 ± 2.5 years at the time of implantation). We analyzed the treatment effectiveness at 1, 2, and 5 year follow-up visits. We counted the average number of urgent hospitalizations and number of days of urgent hospitalization per year for each patient before and after the VNS implantation.

Results: The mean seizure reduction was 42.5% at 1 year, 54.9% at 2 years, and 58.3% at 5 years. The number of responders was 7 (46.7%) at 1 year and 9 (60%) at both 2 and 5 years. The mean number of urgent hospitalizations per patient was 1.0 ± 0.6 per year preoperatively and 0.3 ± 0.5 per year post-operatively (P < 0.0001). The mean number of days of urgent hospitalization per patient was 9.3 ± 6.1 per year preoperatively and 1.3 ± 1.8 per year post-operatively ( < 0.0001).

Conclusions: Vagus nerve stimulation is an effective method of treating children with refractory focal epilepsy. It leads to a substantial decrease in the number and duration of urgent hospitalizations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anticonvulsants / therapeutic use
  • Child
  • Cough / etiology
  • Deglutition Disorders / etiology
  • Emergencies / epidemiology
  • Epilepsies, Partial / drug therapy
  • Epilepsies, Partial / therapy*
  • Epilepsy, Tonic-Clonic / drug therapy
  • Epilepsy, Tonic-Clonic / therapy
  • Female
  • Follow-Up Studies
  • Heart Arrest / etiology
  • Hospitalization / statistics & numerical data
  • Humans
  • Incidence
  • Male
  • Recurrence
  • Retrospective Studies
  • Treatment Outcome
  • Vagus Nerve Stimulation* / adverse effects

Substances

  • Anticonvulsants